02The Operating Platform

One platform. Three operating engines. One value creation model.

Investment, manufacturing, and commercialization operate as one integrated system — designed for differentiated MedTech with proven approvals.

2.1Three Engines

Merova Ventures

Ownership

Strategic ownership in emerging-growth, IP-backed MedTech companies with approvals in the USA and Europe.

Emerging-growth allocation · 60%
Follow-on allocation · 25%
Late-stage allocation · 15%

Explore Merova Ventures →

Merova CMO

Manufacturing

Proprietary healthcare products manufactured in Abu Dhabi for portfolio companies under a cost-plus model.

Cost-plus rent and margin
Cost-plus utilized labor
Made in Emirates · in-country value

Explore Merova CMO →

Merova Care Solutions

Market Access

Marketing, registration and sublicensing across the GCC, MENA and India for differentiated healthcare products.

UAE MoH registration pathway
Hospital and provider channels
MENA + India sublicensing

Explore Care Solutions →

Integrated Return Model

Execution

Venture upside combined with recurring operating dividends — a dual-track institutional return profile.

Cumulative platform IRR > 40% [Target]
Ventures 3–5x / 30–40% IRR [Target]
Operating 15% IRR [Target]

Investor Access →

2.2The Eight-Step Operating Process

Source to distribution —
one continuous system.

Source

Originate proprietary, IP-backed MedTech with approvals in the USA and Europe.

Evaluate

Screen for valuation, market fit, regulatory pathway and GCC manufacturability.

Invest

Take strategic ownership through Class A Preferred at the holding level.

Manufacture

Move production into Abu Dhabi under a cost-plus model — Made in Emirates.

Register

Obtain UAE MoH approval and regional regulatory licenses.

Commercialize

Market through hospital networks across the GCC and key MENA markets.

Scale

Sublicense and expand into MENA, India and adjacent emerging markets.

Distribute Returns

Pay venture exits and operating dividends through the dual-track return model.

Integration Note

Each stage is interconnected by a single proprietary governance framework, ensuring the platform operates as a cohesive unit from initial sourcing through to regional scaling.

Forward-Looking Statement

This presentation and any accompanying materials may contain forward-looking statements within the meaning of applicable securities laws. These statements are based on the current expectations, assumptions, and beliefs of Merova Healthcare Holding Limited ("Merova") and involve risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. Forward-looking statements include, but are not limited to, expectations regarding investment performance, anticipated returns, the growth and success of portfolio companies, future financial results, operational plans, and strategic initiatives. Statements that include words such as "anticipate," "believe," "expect," "intend," "plan," "may," "will," "should," "could," "estimate," and similar expressions are intended to identify such forward-looking statements. Actual results may differ significantly due to various risks and uncertainties, including but not limited to market conditions, regulatory changes, the ability of investee companies to achieve their business objectives, supply chain disruptions, competition, general economic conditions, and other factors beyond Merova's control. There can be no assurance that any forward-looking statements will prove to be accurate, and past performance is not indicative of future results. Merova undertakes no obligation to update or revise any forward-looking statements except as required by law. Prospective investors should conduct their own independent assessment of Merova's investment strategy, risks, and opportunities and should consult their own legal, financial, and tax advisors before making any investment decisions.